TY - GEN
T1 - Mechanistic Implications for Escherichia coli Cofactor-dependent Phosphoglycerate Mutase Based on the High-Resolution Crystal Structure of a Vanadate Complex
AU - Bond, CS
AU - White, Malcolm Frederick
AU - Hunter, WN
N1 - J Mol Biol
PY - 2002/3/8
Y1 - 2002/3/8
N2 - The structure of Escherichia coli cofactor-dependent phosphoglycerate mutase (dPGM), complexed with the potent inhibitor vanadate, has been determined to a resolution of 1.30 Angstrom (R-factor 0.159; R-free 0.213). The inhibitor is present in the active site, principally as divanadate, but with evidence of additional vanadate moieties at either end, and representing a different binding mode to that observed in the structural homologue prostatic acid phosphatase. The analysis reveals the enzyme-ligand interactions involved in inhibition of the mutase activity by vanadate and identifies a water molecule, observed in the native E. coli dPGM structure which, once activated by vanadate, may dephosphorylate the active protein. Rather than reflecting the active conformation previously observed for E. coli dPGM, the inhibited protein's conformation resembles that of the inactive dephosphorylated Saccharomyces cerevisiae dPGM. The provision of a high-resolution structure of both active and inactive forms of dPGM from a single organism, in conjunction with computational modelling of substrate molecules in the active site provides insight into the binding of substrates and the specific interactions necessary for three different activities, mutase, synthase and phosphatase, within a single active site. The sequence similarity of E. coli and human dPGMs allows us to correlate stucture with clinical pathology. (C) 2002 Elsevier Science Ltd.
AB - The structure of Escherichia coli cofactor-dependent phosphoglycerate mutase (dPGM), complexed with the potent inhibitor vanadate, has been determined to a resolution of 1.30 Angstrom (R-factor 0.159; R-free 0.213). The inhibitor is present in the active site, principally as divanadate, but with evidence of additional vanadate moieties at either end, and representing a different binding mode to that observed in the structural homologue prostatic acid phosphatase. The analysis reveals the enzyme-ligand interactions involved in inhibition of the mutase activity by vanadate and identifies a water molecule, observed in the native E. coli dPGM structure which, once activated by vanadate, may dephosphorylate the active protein. Rather than reflecting the active conformation previously observed for E. coli dPGM, the inhibited protein's conformation resembles that of the inactive dephosphorylated Saccharomyces cerevisiae dPGM. The provision of a high-resolution structure of both active and inactive forms of dPGM from a single organism, in conjunction with computational modelling of substrate molecules in the active site provides insight into the binding of substrates and the specific interactions necessary for three different activities, mutase, synthase and phosphatase, within a single active site. The sequence similarity of E. coli and human dPGMs allows us to correlate stucture with clinical pathology. (C) 2002 Elsevier Science Ltd.
KW - crystal structure
KW - enzyme mechanism
KW - Escherichia coli
KW - phosphoglycerate mutase
KW - vanadate
KW - TRANSITION-STATE ANALOGS
KW - BISPHOSPHOGLYCERATE MUTASE
KW - ESTROGEN SULFOTRANSFERASE
KW - IN-VIVO
KW - PHOSPHATASE
KW - SEQUENCE
KW - ANGSTROM
KW - MODEL
KW - REFINEMENT
KW - DEFICIENCY
UR - http://www.scopus.com/inward/record.url?scp=0036304272&partnerID=8YFLogxK
U2 - 10.1006/jmbi.2001.5418
DO - 10.1006/jmbi.2001.5418
M3 - Other contribution
VL - 316
ER -